TY - JOUR
T1 - Curcumin Efficacy in a Serum/Glucose Deprivation-Induced Neuronal PC12 Injury Model
AU - Farkhondeh, Tahereh
AU - Ashrafizadeh, Milad
AU - Azimi-Nezhad, Mohsen
AU - Samini, Fariborz
AU - Aschner, Michael
AU - Samarghandian, Saeed
N1 - Publisher Copyright:
© 2021 Bentham Science Publishers.
PY - 2021/12
Y1 - 2021/12
N2 - Background: Glucose/serum deprivation (GSD), has been used for understanding molecular mechanisms of neuronal damage during ischemia. It has been suggested that curcumin may improve neurodegenerative diseases. Aim: In this study, the protective effects of curcumin and its underlying mechanisms were investi-gated in PC12 cells upon GSD-induced stress. Methods: PC12 cells were cultured in DMEM overnight and then incubated in GSD condition for either 6 or 12h. GSD-treated cells were pretreated with various concentrations of curcumin (10, 20, and 40 μM) for 5h. The cell viability, apoptosis, reactive oxygen species (ROS) level, oxidative stress, expression of apoptosis-related genes, and IL-6 were determined. Results: Curcumin increased cell viability and caused an anti-apoptotic effect in PC12 cells exposed for 12h to GSD . Curcumin also increased antioxidant enzyme expression, suppressed lipid peroxidation, and decreased interleukin-6 secretion in PC12 cells subjected to GSD. In addition, pretreatment with curcumin down-regulated pro-apoptotic (Bax), and up-regulated antiapoptotic (Bcl2) mediators. Conclusion: Curcumin mitigates many of the adverse effects of ischemia, and therefore, should be considered as an adjunct therapy in ischemic patients.
AB - Background: Glucose/serum deprivation (GSD), has been used for understanding molecular mechanisms of neuronal damage during ischemia. It has been suggested that curcumin may improve neurodegenerative diseases. Aim: In this study, the protective effects of curcumin and its underlying mechanisms were investi-gated in PC12 cells upon GSD-induced stress. Methods: PC12 cells were cultured in DMEM overnight and then incubated in GSD condition for either 6 or 12h. GSD-treated cells were pretreated with various concentrations of curcumin (10, 20, and 40 μM) for 5h. The cell viability, apoptosis, reactive oxygen species (ROS) level, oxidative stress, expression of apoptosis-related genes, and IL-6 were determined. Results: Curcumin increased cell viability and caused an anti-apoptotic effect in PC12 cells exposed for 12h to GSD . Curcumin also increased antioxidant enzyme expression, suppressed lipid peroxidation, and decreased interleukin-6 secretion in PC12 cells subjected to GSD. In addition, pretreatment with curcumin down-regulated pro-apoptotic (Bax), and up-regulated antiapoptotic (Bcl2) mediators. Conclusion: Curcumin mitigates many of the adverse effects of ischemia, and therefore, should be considered as an adjunct therapy in ischemic patients.
KW - Apoptosis
KW - Curcumin
KW - Cytotoxicity
KW - Inflammation
KW - Oxidative stress
KW - PC12 cell
KW - Serum/glucose deprivation
UR - http://www.scopus.com/inward/record.url?scp=85103081471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103081471&partnerID=8YFLogxK
U2 - 10.2174/1874467214666210203211312
DO - 10.2174/1874467214666210203211312
M3 - Article
C2 - 33538682
AN - SCOPUS:85103081471
SN - 1874-4702
VL - 14
SP - 1146
EP - 1155
JO - Current Molecular Pharmacology
JF - Current Molecular Pharmacology
IS - 6
ER -